These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 26440527)

  • 1. Endothelin ETA receptor antagonist reverses naloxone-precipitated opioid withdrawal in mice.
    Bhalla S; Pais G; Tapia M; Gulati A
    Can J Physiol Pharmacol; 2015 Nov; 93(11):935-44. PubMed ID: 26440527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurobiology of opioid withdrawal: Role of the endothelin system.
    Bhalla S; Andurkar SV; Gulati A
    Life Sci; 2016 Aug; 159():34-42. PubMed ID: 26796510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Cannabinoid Receptor Type 1 Positive Allosteric Modulator ZCZ011 Attenuates Naloxone-Precipitated Diarrhea and Weight Loss in Oxycodone-Dependent Mice.
    Dodu JC; Moncayo RK; Damaj MI; Schlosburg JE; Akbarali HI; O'Brien LD; Kendall DA; Wu Z; Lu D; Lichtman AH
    J Pharmacol Exp Ther; 2022 Jan; 380(1):1-14. PubMed ID: 34625464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relative potency of inverse opioid agonists and a neutral opioid antagonist in precipitated withdrawal and antagonism of analgesia and toxicity.
    Sirohi S; Dighe SV; Madia PA; Yoburn BC
    J Pharmacol Exp Ther; 2009 Aug; 330(2):513-9. PubMed ID: 19435929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphine tolerance does not develop in mice treated with endothelin-A receptor antagonists.
    Bhalla S; Matwyshyn G; Gulati A
    Brain Res; 2005 Dec; 1064(1-2):126-35. PubMed ID: 16289404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological modulation of leukotriene D(4) attenuates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome.
    Rehni AK; Singh I; Singh N; Bansal N; Bansal S; Kumar M
    Eur J Pharmacol; 2008 Nov; 598(1-3):51-6. PubMed ID: 18840427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel combination of opiates and endothelin antagonists to manage pain without any tolerance development.
    Gulati A; Bhalla S; Matwyshyn G
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S129-31. PubMed ID: 15838261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of supraspinal and peripheral naloxonazine-insensitive opioid receptor sites in the expression of μ-opioid receptor agonist-induced physical dependence.
    Mori T; Komiya S; Uzawa N; Inoue K; Itoh T; Aoki S; Shibasaki M; Suzuki T
    Eur J Pharmacol; 2013 Sep; 715(1-3):238-45. PubMed ID: 23707904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuation of opioid analgesic tolerance in p75 neurotrophin receptor null mutant mice.
    Trang T; Koblic P; Kawaja M; Jhamandas K
    Neurosci Lett; 2009 Feb; 451(1):69-73. PubMed ID: 19114089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of opioid withdrawal and potentiation of acute opioid analgesia by systemic AV411 (ibudilast).
    Hutchinson MR; Lewis SS; Coats BD; Skyba DA; Crysdale NY; Berkelhammer DL; Brzeski A; Northcutt A; Vietz CM; Judd CM; Maier SF; Watkins LR; Johnson KW
    Brain Behav Immun; 2009 Feb; 23(2):240-50. PubMed ID: 18938237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear factor-kappa-B inhibitor modulates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome.
    Rehni AK; Bhateja P; Singh TG; Singh N
    Behav Pharmacol; 2008 May; 19(3):265-9. PubMed ID: 18469544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fecal microbiota transplantation and antibiotic treatment attenuate naloxone-precipitated opioid withdrawal in morphine-dependent mice.
    Thomaz AC; Iyer V; Woodward TJ; Hohmann AG
    Exp Neurol; 2021 Sep; 343():113787. PubMed ID: 34153321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of tizanidine administration on precipitated opioid withdrawal signs in rats.
    Pinelli A; Trivulzio S; Spezia R
    Drug Alcohol Depend; 1998 Mar; 50(1):81-8. PubMed ID: 9589275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuation of opioid tolerance by ET
    Gulati S; Briyal S; Jones S; Bhalla S; Gulati A
    Heliyon; 2017 Jun; 3(6):e00317. PubMed ID: 28626808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuation of opioid tolerance by ETA receptor antagonist, BQ123, administered intravenously in mice.
    Bhalla S; Lyne J; Gulati A; Andurkar SV
    J Pharm Pharmacol; 2022 May; 74(5):769-778. PubMed ID: 35355073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentiation of morphine analgesia by BQ123, an endothelin antagonist.
    Bhalla S; Matwyshyn G; Gulati A
    Peptides; 2002 Oct; 23(10):1837-45. PubMed ID: 12383872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disulfiram attenuates morphine or methadone withdrawal syndrome in mice.
    de Cordé A; Krząścik P; Wolińska R; Kleczkowska P; Filip M; Bujalska-Zadrożny M
    Behav Pharmacol; 2018 Aug; 29(5):393-399. PubMed ID: 29462108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baclofen prevents the elevated plus maze behavior and BDNF expression during naloxone precipitated morphine withdrawal in male and female mice.
    Pedrón VT; Varani AP; Balerio GN
    Synapse; 2016 May; 70(5):187-97. PubMed ID: 26789010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tramadol antinociception is potentiated by clonidine through α₂-adrenergic and I₂-imidazoline but not by endothelin ET(A) receptors in mice.
    Andurkar SV; Gendler L; Gulati A
    Eur J Pharmacol; 2012 May; 683(1-3):109-15. PubMed ID: 22449379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naloxone rapidly evokes endogenous kappa opioid receptor-mediated hyperalgesia in naïve mice pretreated briefly with GM1 ganglioside or in chronic morphine-dependent mice.
    Crain SM; Shen KF
    Brain Res; 2007 Sep; 1167():31-41. PubMed ID: 17692296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.